Diabetes News

Most diabetes care and education specialists said they believe it is important to screen for presymptomatic type 1 diabetes, though some said they had limited knowledge regarding teplizumab-mzwv, according to a presenter.

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Isabel C. Betancourt, MS, RDN, CDCES, about nutrition insecurity and how a model designed to combat its effects on people with HIV can improve the lives of people with diabetes.

Tandem Diabetes Care emailed notices to users of version 2.7.1 of the Apple iOS t:connect mobile app warning of possible rapid battery depletion of their insulin pump, according to an FDA press release.

Adults with type 2 diabetes who are referred to a clinical pharmacist are more likely to meet their HbA1c goal and receive appropriate medication management of comorbidities than people receiving usual care, according to a presenter.

A multifaceted intervention implemented at a U.S. hospital reduced insulin pen waste by 18.3% in inpatient adult areas, according to a presenter at the Association of Diabetes Care and Education Specialists annual meeting.

SGLT2 inhibitors were associated with similar renal and CV outcomes vs. GLP-1 receptor agonists for patients with diabetes, regardless of chronic kidney disease status, researchers reported.

In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.

Adults with type 2 diabetes using a GLP-1 receptor agonist are less likely to develop hyperkalemia than those using a DPP-IV inhibitor, according to a study published in JAMA Internal Medicine.

Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open.